Research article
A compact VEGF signature associated with distant metastases and poor outcomes
-
* Corresponding author: Charles M Perou cperou@med.unc.edu
1 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
2 Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
3 Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
4 Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
5 Department of Pathology, Stanford University Medical Center, Stanford, CA 94035, USA
6 Section of Hematology/Oncology, Department of Medicine, Committees on Genetics and Cancer Biology, University of Chicago, South Maryland Avenue, Chicago, IL 60637-1463, USA
BMC Medicine 2009, 7:9 doi:10.1186/1741-7015-7-9
Published: 16 March 2009Additional files
Additional file 1:
Supplementary table. Summary of GEO submission of 202 microarrays used in this paper and clinical data of the patients in this study.
Format: XLS Size: 71KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 2:
Figure S1. The complete cluster diagram of all 146 patients using the 1195 gene. MetScore-associated gene list.
Format: PDF Size: 692KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 3:
Figure S2. Univariate Kaplan-Meier survival plots for patients stratified using the VEGF profile based upon rank order expression on the A-B) UNC training data set, C-D) NKI test data set, E-F) Bhattacharjee et al [29] lung carcinoma data set, and G-H) Nutt et al [30] glioblastoma data set.
Format: PDF Size: 284KB Download file
This file can be viewed with: Adobe Acrobat Reader